Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Infinum Enables Companies to Integrate Their Apps and Services Directly into ChatGPT
-
Spectral Capital Announces Projected $450,000,000 in Projected 2026 Revenue in Connection with NASDAQ Uplisting; Engages Revere Securities
-
US Air Force Awards ThroughPut.ai Phase III Contract for "Aircraft Availability Optimization"
-
Epique Realty Expands CliqueOffers Benefit, Launching Powerful B2C Cash Offer Marketing for Agents
-
Northern Graphite Grants Stock Options to Non-Executive Directors
-
Viscount Strengthens Gold-Copper Porphyry Model at Passiflora as Multiple Exploration Datasets Align
-
DeConna Ice Cream and PPM Solar celebrate completion of 794 kW solar energy system at Reddick facility
-
Prosafe SE: Mandatory notification of trade
-
IODeFi Launches Next-Generation Automated Yield App for BTC & ETH Holders A New Step Forward in Hands-Free Digital Asset Growth
-
From Research to Measurable Patient Outcomes, Bio-IT World Conference & Expo Celebrates 25th Annual Event Advancing the Future of Precision Medicine
-
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market
-
Ajust Design Adds Strategic Communication Practice as Private Equity Firms Encounter Growing Competition for Capital
-
Ability Biotherapeutics Appoints Angèle Maki, PhD, as Chief Business Officer
-
ZenaTech Enters UK Market Closing Drone-as-a-Service Acquisition of Casado Design Ltd., Expanding to the Growing Telecom Tower Design and Infrastructure Sector
-
Greene Concepts Reflects on Its Journey of Renewal, Resilience, and National Growth with Be Water(TM)
-
Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple
-
OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected
-
CHARBONE Taps Air Liquide Veteran Ahead of First Revenue From Flagship Project
-
Elanco Investor Day Defines New Era as Sustainable Growth Company
-
MassMedia Accelerates Paid Media Capabilities With Leadership Appointment of Kristen Carter
-
BibleVerseArt.co Launches a New Collection of Faith-Inspired Wall Art for Every Home
-
PropertyManagementMalta.co Introduces Full-Service Property Management for Maltese Rentals
-
From a Simple Idea to a Global Standard: EV Blocks Founder Wins Global Entrepreneur of the Year 2025
-
Solar A/S: No. 19 2025 Major shareholder announcement
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Valkea Resources Strengthens the Bulk-Tonnage Gold Potential of the Koivu Zone at the Paana Project, Northern Finland
-
Kenorland Minerals Provides an Exploration Update
-
REPEAT – QGold to Host Live Webinar to Discuss Corporate Update
-
Revival Gold Provides Update and Latest Results From Drilling at the Mercur Gold Project in Utah
-
AGF Management Limited Declares Fourth Quarter 2025 Dividend
-
Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO® (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology
-
Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
-
MarketAxess Announces Medium-Term Financial Targets¹ Increases Stock Repurchase Authorization to $505 million Intends to Effect an Accelerated Stock Repurchase
-
Gold Reserve Provides Update in CITGO Sale Process: Gold Reserve Files Statement in Support of Stay Pending Appeal
-
Pirtobrutinib Outperforms Bendamustine Plus Rituximab for Previously Untreated CLL/SLL
-
Soluna Announces Monthly Business Update
-
Tec-Dara Combination Offers Substantial Improvement Over Standard Second-Line Therapies for Relapsed or Refractory Multiple Myeloma
-
Hess Midstream LP Announces 2026 Guidance, Extends Return of Capital Program
-
Kelonia Therapeutics Presents First-in-Human Data From Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the American Society of Hematology (ASH) 2025 Annual Meeting
-
Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia
-
Drug Reduced Need for Blood Transfusions During Hospitalization for Non-Cardiac Surgery
-
Noble Mineral Exploration Inc. Announces Diamond Drill Program Which has Commenced in the Timmins Area
-
Menlo Ventures’ 2025 State of Generative AI Report: Enterprise Investment Hit $37B in 2025, Tripling in One Year
-
ALT5 Sigma Corporation Provides Corporate Update
-
XCharge North America Selected by Cellerate Power to Deploy Vermont's Fastest EV Chargers
-
Accomplished Communications Leader Ann Hemingway Joins Sam Brown as Managing Director, Account Services
-
Pariveda Named a 2025 Geo and Global AWS Partner Award Finalist
-
Real Expands Southern California Footprint as Top Producer Freeman Wang and 50-Agent Team Join the Brokerage
-
Pariveda Awarded a 2025 AWS Partner Award
-
NanoXplore Announces Nima Moghimian as Chief Technology Officer
